Tandem Diabetes Care, Inc. (FRA:TD5A)
Germany · Delayed Price · Currency is EUR 18.57
+0.21 (1.14%)
Last updated: Nov 25, 2025, 8:04 AM CET
Tandem Diabetes Care Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,007 | 940.2 | 747.72 | 801.22 | 702.8 | 498.83 | Upgrade | |
Revenue Growth (YoY) | 17.87% | 25.74% | -6.68% | 14.00% | 40.89% | 37.68% | Upgrade |
Cost of Revenue | 470.99 | 450.63 | 380.03 | 388.23 | 326.58 | 238.31 | Upgrade |
Gross Profit | 536.01 | 489.57 | 367.69 | 412.99 | 376.22 | 260.52 | Upgrade |
Selling, General & Admin | 426.87 | 389.82 | 338.4 | 335.68 | 261.51 | 204.9 | Upgrade |
Research & Development | 196.14 | 198.88 | 169.67 | 139.11 | 92.05 | 63.57 | Upgrade |
Operating Expenses | 623.01 | 588.7 | 508.07 | 474.8 | 353.56 | 268.48 | Upgrade |
Operating Income | -87 | -99.13 | -140.38 | -61.81 | 22.65 | -7.96 | Upgrade |
Interest Expense | -7.69 | -7.42 | -9.88 | -6.21 | -6.04 | -12.81 | Upgrade |
Interest & Investment Income | 16.5 | 22.1 | 21.2 | 6.06 | 0.67 | 1.57 | Upgrade |
Earnings From Equity Investments | -21.29 | -2.05 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -7 | -2 | 1.5 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 12.68 | -0.11 | 0.16 | 0.15 | -1.39 | -17.09 | Upgrade |
EBT Excluding Unusual Items | -93.8 | -88.6 | -127.4 | -61.81 | 15.9 | -36.28 | Upgrade |
Gain (Loss) on Sale of Investments | -2 | -2 | - | - | - | - | Upgrade |
Asset Writedown | -6.7 | - | -14.1 | - | - | - | Upgrade |
Other Unusual Items | - | -1.27 | - | - | - | - | Upgrade |
Pretax Income | -204.94 | -91.87 | -220.25 | -92.85 | 15.9 | -36.28 | Upgrade |
Income Tax Expense | -1.57 | 4.16 | 2.36 | 1.74 | 0.34 | -1.9 | Upgrade |
Net Income | -203.37 | -96.03 | -222.61 | -94.59 | 15.57 | -34.38 | Upgrade |
Net Income to Common | -203.37 | -96.03 | -222.61 | -94.59 | 15.57 | -34.38 | Upgrade |
Shares Outstanding (Basic) | 67 | 65 | 65 | 64 | 63 | 61 | Upgrade |
Shares Outstanding (Diluted) | 67 | 65 | 65 | 64 | 64 | 61 | Upgrade |
Shares Change (YoY) | 2.23% | 0.74% | 1.28% | -0.32% | 5.51% | 4.24% | Upgrade |
EPS (Basic) | -3.05 | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 | Upgrade |
EPS (Diluted) | -3.05 | -1.47 | -3.43 | -1.47 | 0.24 | -0.56 | Upgrade |
Free Cash Flow | -25.13 | 4.99 | -58.61 | 16.37 | 97.18 | -2.74 | Upgrade |
Free Cash Flow Per Share | -0.38 | 0.08 | -0.90 | 0.26 | 1.51 | -0.04 | Upgrade |
Gross Margin | 53.23% | 52.07% | 49.18% | 51.54% | 53.53% | 52.23% | Upgrade |
Operating Margin | -8.64% | -10.54% | -18.77% | -7.71% | 3.22% | -1.59% | Upgrade |
Profit Margin | -20.20% | -10.21% | -29.77% | -11.81% | 2.21% | -6.89% | Upgrade |
Free Cash Flow Margin | -2.50% | 0.53% | -7.84% | 2.04% | 13.83% | -0.55% | Upgrade |
EBITDA | -69.58 | -82.52 | -124.67 | -47.48 | 36.5 | 2.49 | Upgrade |
EBITDA Margin | -6.91% | -8.78% | -16.67% | -5.93% | 5.19% | 0.50% | Upgrade |
D&A For EBITDA | 17.42 | 16.61 | 15.72 | 14.33 | 13.85 | 10.45 | Upgrade |
EBIT | -87 | -99.13 | -140.38 | -61.81 | 22.65 | -7.96 | Upgrade |
EBIT Margin | -8.64% | -10.54% | -18.77% | -7.71% | 3.22% | -1.59% | Upgrade |
Effective Tax Rate | - | - | - | - | 2.11% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.